X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Neurodevelopmental Issue Leads To Testicular Cancer Risk

Content Team by Content Team
27th April 2023
in News, Research & Development
Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

A novel study by researchers at Uppsala University as well as its hospital has shown that men who happen to have a neurodevelopmental disorder like autism or ADHD have a higher risk of show this kind of link.

It has been penned in the British Journal of Cancer. It is well to be noted that testicular cancer happens to be the most common of all cancers among young men, and what it is caused by is still not known. As per Ingrid Glimelius, the Department of Oncology’s senior consultant at the Uppsala Hospital and also a professor at Uppsala University, testicular cancer can very well be surgically removed, thereby curing the disease. It is, however, very important to seek care without delay if any kind of lump is felt inside the testicle.

The novel research focused on patients who had testicular cancer across Sweden. 6,166 individuals were included in the research and were compared to 61,660 age-matched men who did not have testicular cancer. Notably, medical register data was used to investigate if psychiatric diagnoses before cancer diagnoses happened to be more common in patients who had testicular cancer in the control group.

Generally put, the scientists did not find any elevated risk of testicular cancer in patients who had psychiatric diagnosis; that said, the group with neurodevelopmental disorder in particular saw a prominent rise in the risk of having seminoma-type testicular cancer.

While the researchers did find that there was an elevated seminoma risk in people with neurodevelopmental disorders, absolute risk surge was lower than 1%. This puts light on the fact that the testicular cancer risk is still very low in boys and men who are suffering from conditions such as autism as well as ADHD. There is indeed no need to feel the pinch if one has these diagnoses.

That said, the results happen to be intriguing when it comes to attempts to get closer to discussing mechanisms concerning the occurrence of testicular cancer.

As per Anna Johnson, an Uppsala University doctoral student as well as a physician at the hospital, they also saw that people with past psychiatric evaluations had a higher risk of succumbing to testicular cancer as compared to people who did not have a prior psychiatric diagnosis. That said, the testicular cancer survival rate was pretty good in both groups.

Apparently, this is the first research study that provides a link between testicular cancer risk and neurodevelopmental disorders. Prior to this, the risk factors included having an undescended testicle as a kid or having a brother or father who were suffering from testicular cancer.

Johnson continues that they really do not know why a link is observed between neurodevelopmental disorders and testicular cancer; however, they do believe that early life events, perhaps as early as the foetal stage, do have an impact.

As per Glimelius, since there is a reduced survival rate in people with mental health issues, it is indeed significant for the healthcare system, the individuals, and their families to be very well aware that they might as well get affected due to another illness. He further says that treatment must be sought if a lump is felt inside the testicle and that this disease can be cured in most people today.

Previous Post

Malaria Immunity Boosted By Matrix-M, Saponin Based Adjuvant

Next Post

Viral Infections Curbed By Gene Scissors In Human Cells

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

Viral Infections Curbed By Gene Scissors In Human Cells

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In